<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01182025</url>
  </required_header>
  <id_info>
    <org_study_id>200907001-4</org_study_id>
    <nct_id>NCT01182025</nct_id>
  </id_info>
  <brief_title>A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing University of Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the effectiveness and safety of Xiyanping Injection for
      mild type of hand, foot, and mouth disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      By adopting a multi-center, randomized and controlled clinical trial, this study is aimed to
      evaluate the efficacy and safety of Xiyanping Injection in the treatment of mild type of
      Hand, Foot and Mouth Disease (HFMD), and designed to combine both observational and
      interventional methodologies in this research.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time of bringing down the fever</measure>
    <time_frame>10 days</time_frame>
    <description>Refering to the length of time to bring down the fever by 0.5 degrees Celsius after the medicine is taken.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>time of body temperature going back to normal</measure>
    <time_frame>10 days</time_frame>
    <description>Refering to the time of the armpit temperature of lower than 37.0 degrees Celsius, lasting for at least 24 hours, after the medicine is taken.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time of symptom disappearance</measure>
    <time_frame>10 days</time_frame>
    <description>Refering to the length of time when clinical symptoms and signs totally disappere after the medicine is used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>case severity rate</measure>
    <time_frame>10 days</time_frame>
    <description>Refering to the ratio of patient with mild type of HFMD to severe type, such as damage of central nervous system, pulmonary edema, heart failure, respiratory failure, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time of tetter disappearance</measure>
    <time_frame>10 days</time_frame>
    <description>Refering to the length of time when the tetter due to HFMD disappears, characterised by scab(s) or dropping; and time of oral ulcer concrescence, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>direct medical cost</measure>
    <time_frame>10 days</time_frame>
    <description>Referring to the costs in the treatment of HFMD and relative disease, including the registration fee, examination fee, and drug fees, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>safety outcome</measure>
    <time_frame>10 days</time_frame>
    <description>Calculated by adverse event.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Hand, Foot and Mouth Disease</condition>
  <arm_group>
    <arm_group_label>Western therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Xiyanping Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Xiyanping Injection with western medicine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Western therapy</intervention_name>
    <description>Symptomatic treatment: vitamin B, vitamin C, mouth care and skin care.
Adopting physical cooling therapy, including physical cooling paste or warm bathing, when patient's body temperature is lower than 38.5 degree Celsius;
Using Ibuprofen suspension when patient's temperature higher than 38.5 degree Celsius;</description>
    <arm_group_label>Western therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xiyanping Injection</intervention_name>
    <description>Dosage for child medication:
5-10mg/kg/d (0.2-0.4ml/kg/d) in 5% Glucose solution, IV, with speed of 20-30 drops per minute, each day; or as directed by doctor.</description>
    <arm_group_label>Xiyanping Injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xiyanping Injection with western medicine</intervention_name>
    <description>Symptomatic treatment using the same treatment methods in western therapy group;
Symptomatic treatment using the same treatment methods in Xiyanpin injection group.</description>
    <arm_group_label>Xiyanping Injection with western medicine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of severe hand-foot-mouth disease patients according to
             Hand-Foot-Mouth Disease Treatment Guidelines 2010 issued by China's Ministry of
             Health; More than 1/3 patients should be diagnosed by etiological examination.

          -  Less than 48 hours of occurrence of fever and/or occurrence of tetter or herpes.

          -  Age of 1-14 years.

          -  Patients or their guardians agree to participate in this study and signed the informed
             consent form.

        Exclusion Criteria:

          -  Complicated with other serious primary diseases in organ such as congenital heart
             disease, chronic hepatitis, nephritis and blood diseases, etc.

          -  With history of allergies on traditional Chinese medicine.

          -  Patients or their guardians suffering from Psychiatric diseases.

          -  Attending other clinical studies on HFMD after diagnosed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guoliang Zhang</last_name>
    <role>Principal Investigator</role>
    <affiliation>An'Hui Chinese Medical College Affiliated No.1 Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Affiliated Hospital of Guilin Medical College</name>
      <address>
        <city>Guilin</city>
        <state>Guangxi</state>
        <zip>541001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiong Li</last_name>
      <phone>13737728526</phone>
      <email>yuanyanhui_888@163.com</email>
    </contact>
    <investigator>
      <last_name>Xiong Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liuzhou Worker's Hospital</name>
      <address>
        <city>Liuzhou</city>
        <state>Guangxi</state>
        <zip>541001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liuping Tang</last_name>
      <phone>18977228768</phone>
      <email>yongren126zeng@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Zhe Guo</last_name>
      <phone>13978009767</phone>
      <email>sdy761212@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Liuping Tang</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhe Guo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liuzhou People's Hospital</name>
      <address>
        <city>Liuzhou</city>
        <state>Guangxi</state>
        <zip>545001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tong Yang</last_name>
      <phone>13977286628</phone>
      <email>zhoubing-1995@163.com</email>
    </contact>
    <investigator>
      <last_name>Tong Yang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shenzhen Maternity &amp; Child Healthcare Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangzhou</state>
        <zip>518028</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinying Zou</last_name>
      <phone>13129559135</phone>
      <email>Xuzhiymr@yahoo.com.cn</email>
    </contact>
    <investigator>
      <last_name>Xinying Zou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jiangxi Provincial Children's Hospital</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <zip>330006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qingxiong Zhu</last_name>
      <phone>15979003000</phone>
      <email>Zhuqingxiong2000@163.com</email>
    </contact>
    <investigator>
      <last_name>Qingxiong Zhu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 13, 2010</study_first_submitted>
  <study_first_submitted_qc>August 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2010</study_first_posted>
  <last_update_submitted>August 16, 2010</last_update_submitted>
  <last_update_submitted_qc>August 16, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2010</last_update_posted>
  <responsible_party>
    <name_title>Guoliang Zhang</name_title>
    <organization>The First Affiliated Hospital of Anhui College of Traditional Chinese Medicine</organization>
  </responsible_party>
  <keyword>Mild type of hand, foot and mouth disease</keyword>
  <keyword>Xiyanping Injection</keyword>
  <keyword>Effectiveness</keyword>
  <keyword>Safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth Diseases</mesh_term>
    <mesh_term>Foot-and-Mouth Disease</mesh_term>
    <mesh_term>Hand, Foot and Mouth Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

